PUTNOE MEDICAL CENTRE PARTNERSHIP — All Prescriptions & Medications — Page 7
Practice Code: E81029 | BEDFORD, MK41 9JE
Showing results 301-350 of 666
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Zolmitriptan | 100 | 1,220 | £3.6K | +54.0% ▲ |
| Hydralazine hydrochloride | 99 | 8,960 | £451 | +134.6% ▲ |
| Adrenaline | 97 | 190 | £11.3K | +53.8% ▲ |
| 97 | 320 | £822 | +300.4% ▲ | |
| Rizatriptan | 96 | 765 | £2.0K | +61.5% ▲ |
| Clobazam | 95 | 7,907 | £1.7K | +44.1% ▲ |
| 95 | 95 | £559 | +85.2% ▲ | |
| Biphasic insulin aspart | 94 | 810 | £4.8K | -7.4% ▼ |
| Celecoxib | 94 | 4,722 | £358 | +42.3% ▲ |
| Dorzolamide | 94 | 4,765 | £2.0K | +13.1% ▲ |
| Ropinirole hydrochloride | 93 | 4,956 | £2.0K | -12.5% ▼ |
| Sodium bicarbonate | 93 | 15.9K | £723 | +0.6% vs avg |
| Cyclizine lactate | 89 | 1,055 | £1.0K | +493.3% ▲ |
| Terbinafine hydrochloride | 88 | 4,452 | £1.6K | +42.4% ▲ |
| Telmisartan | 87 | 5,208 | £1.2K | +50.1% ▲ |
| Desmopressin acetate | 87 | 4,622 | £4.0K | +66.8% ▲ |
| Terbinafine hydrochloride | 87 | 3,060 | £562 | +134.5% ▲ |
| 87 | 207 | £17.3K | +143.6% ▲ | |
| Powder 1.6 kcal/ml milkshake (0913011) | 86 | 9,731 | £1.8K | +15.3% ▲ |
| Bupivacaine hydrochloride | 86 | 119 | £561 | +79.9% ▲ |
| Glycerol | 85 | 1,198 | £190 | +142.3% ▲ |
| Pramipexole | 85 | 9,090 | £1.3K | -13.4% ▼ |
| Oral rehydration salts | 85 | 658 | £307 | +194.2% ▲ |
| Ketoconazole | 85 | 12.0K | £1.6K | -13.4% ▼ |
| 85 | 2,450 | £853 | +9.9% ▲ | |
| Other multivitamin preparations | 83 | 2,487 | £531 | -52.0% ▼ |
| Peppermint oil | 82 | 8,120 | £659 | +3.1% ▲ |
| Amiloride hydrochloride | 82 | 1,757 | £877 | +225.8% ▲ |
| 82 | 2,663 | £1.6K | +19.7% ▲ | |
| Valsartan | 81 | 4,852 | £1.2K | +37.5% ▲ |
| Piroxicam | 81 | 8,120 | £210 | +41.0% ▲ |
| Ciprofloxain/dexameth | 81 | 420 | £489 | +163.8% ▲ |
| Tacrolimus | 81 | 2,940 | £2.3K | +50.2% ▲ |
| 81 | 1,401 | £872 | -20.7% ▼ | |
| 81 | 10.1K | £486 | +49.2% ▲ | |
| Fentanyl | 80 | 687 | £1.7K | -21.9% ▼ |
| Coal tar | 80 | 20.7K | £454 | +9.9% ▲ |
| 80 | 10.1K | £18.1K | +64.1% ▲ | |
| Methotrexate | 79 | 313 | £4.9K | +164.9% ▲ |
| 79 | 2,253 | £5.5K | +98.0% ▲ | |
| Biphasic insulin lispro | 78 | 668 | £4.1K | +81.7% ▲ |
| Linagliptin/metformin | 77 | 7,896 | £4.5K | +128.6% ▲ |
| Leflunomide | 77 | 2,700 | £163 | +103.5% ▲ |
| 77 | 3,318 | £7.6K | +128.0% ▲ | |
| 76 | 206 | £879 | +145.0% ▲ | |
| Vortioxetine | 73 | 2,310 | £2.2K | +5.2% ▲ |
| 73 | 76 | £264 | +125.3% ▲ | |
| 73 | 9,060 | £14.9K | +296.6% ▲ | |
| Amiodarone hydrochloride | 72 | 3,080 | £169 | +11.6% ▲ |
| Alfuzosin hydrochloride | 72 | 3,492 | £1.4K | +0.7% vs avg |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.